Transition to Public Insurance Ups Post-Heart Transplant Death

This article originally appeared here.
Share this content:
Transition to Public Insurance Ups Post-Heart Transplant Death
Transition to Public Insurance Ups Post-Heart Transplant Death

WEDNESDAY, Sept. 14, 2016 (HealthDay News) -- For patients receiving first-time orthotopic heart transplants, transition from private to public health insurance is associated with increased mortality, according to a study published online Sept. 13 in Circulation: Cardiovascular Quality and Outcomes.

Dmitry Tumin, Ph.D., from The Ohio State University College of Medicine in Columbus, and colleagues identified adults aged 18 to 64 years receiving first-time orthotopic heart transplants between July 2006 and December 2013. They categorized patients surviving more than one year according to insurance status trajectory (private versus public) at wait listing, transplantation, and one-year follow-up.

The researchers found that among the 9,088 patients who survived to one year, continuous public insurance and transition from private to public insurance correlated with increased mortality compared with continuous private insurance (hazard ratios, 1.36 and 1.25, respectively). In additional analyses of 11,247 patients with all durations of post-transplant survival, the transition from private to public insurance correlated with increased mortality (hazard ratio, 1.25), while lower mortality was seen for the transition from public to private insurance (hazard ratio, 0.78).

"Transition from private to public insurance after heart transplantation is associated with worse long-term outcomes, compounding disparities in post-transplant survival attributed to insurance status at transplantation," the authors write. "By contrast, post-transplant gain of private insurance among patients receiving publicly funded heart transplants was associated with improved outcomes."

Abstract
Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »


Sign up for myCME e-newsletters


Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

SABCS: Artificial Intelligence May Aid Doctors in Breast Cancer Care

SABCS: Artificial Intelligence May Aid Doctors in Breast ...

'Watson Oncology' agreed with doctors 90 percent of the time in many cases, researchers find

SABCS: Scalp-Cooling System Can Reduce Chemo-Related Hair Loss

SABCS: Scalp-Cooling System Can Reduce Chemo-Related Hair Loss

Devices reduce blood flow to hair follicles during chemotherapy treatments

SABCS: Aromatase Inhibitors Tied to Reduced Endothelial Function

SABCS: Aromatase Inhibitors Tied to Reduced Endothelial Function

Women on aromatase inhibitors exhibit less elasticity in their blood vessels

is free, fast, and customized just for you!

Already a member?

Sign In Now »